Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.

Demirca, Beyza; Cagan, Hasret; Kiykim, Ayca; Arig, Ulku; Arpa, Medeni; Tulunay, Aysin; Ozen, AHMET; Karakoc-Aydiner, ELİF; BARIŞ, SAFA; Barlan, I.

doi:10.1016/j.rmed.2015.07.007

Nebulized fluticasone propionate, a viable alternative to systemic route in the management of childhood moderate asthma attack: A double-blind, double-dummy study.

Atıf İçin Kopyala

Demirca B. P., Cagan H., Kiykim A., Arig U., Arpa M., Tulunay A., ...Daha Fazla

Respiratory medicine, cilt.109, sa.9, ss.1120-5, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 109 Sayı: 9
Basım Tarihi: 2015
Doi Numarası: 10.1016/j.rmed.2015.07.007
Dergi Adı: Respiratory medicine
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1120-5
Marmara Üniversitesi Adresli: Evet

Özet

Background: In this study, we compared the clinical and immunological efficacy of nebulized corticosteroid (CS) to systemic route during treatment of moderate asthma attack in children.